Activa Healthcare has changed its name to L&R
Twice as absorbant for highly exuding wounds
Highly exuding wounds such as leg ulcers are challenging to treat and can be distressing for patients. Excess exudate must be managed appropriately to prevent further deterioration of the wound and the surrounding skin.
Flivasorb is a high quality superabsorbent wound dressing, which absorbs twice as much as traditional absorbent dressings. Flivasorb retains this exudate, including the high level of harmful protease enzymes carried in chronic wound exudate, within the cellulose core.
Flivasorb is effective under compression, meaning a combined approach to treatment can be taken to optimize healing potential.It is particularly effective under Actico which is ideal for chronic oedema where high levels of lymphorrea(wet leaky legs) are common.
Flivasorb has a silky smooth integrated contact layer, reducing the need for an additonal primary protection layer. It is cost effective - helping you manage exudate and your budget.
Flivasorb is available as an adhesive dressing (Flivasorb adhesive) combining the benefits of Flivasorb with a skin friendly, flexible adhesive membrane.
Conform well to healthy skin and facilitate application
Flexible wound contact layer
Prevents adhesion to the wound
Absorbed exudate is evenly distributed and quickly conducted into the absorbent core
Absorbent core with superabsorber
Binds large amounts of wound exudate evenly in fixed superabsorber particles
Flivasorb is a pioneering, superabsorbent wound dressing, with twice as much absorption capacity in comparison to a traditional absorbent dressing.
Superabsorbent polymers (SAP) are polymers that can absorb several times their own weight in liquid (e.g. 20 times as much fluid).
Chemically, a SAP is a long-chain polymer consisting of a polyacrylate (typically sodium polyacrylate). When a liquid comes into contact with a SAP it will attach to these polymer chains and form a complex network structure, resulting in visible swelling and gelling.
Flivasorb will retain some pathogens in the dressing but it will not kill them and is primarily designed for exudate management. It should never be used as the only treatment for critically colonized or infected wounds.
|LR code||PIP code||Hospital code|
|Superabsorbent Dressing 10cm x 10cm||25810||343-4370||EME 026|
|Superabsorbent Dressing 10cm x 20cm||25811||343-4388||EME 027|
|Superabsorbent Dressing 20cm x 20cm||25812||343-4396||EME 028|
|Superabsorbent Dressing 20cm x 30cm||25910||345-0590||EME 029|
|Flivasorb Adhesive Superabsorbent Dressing 12cm x 12cm||30994||366-0826||EME 071|
|Flivasorb Adhesive Superabsorbent Dressing 15cm x 15cm||30995||366-0834||EME 072|
|Flivasorb Adhesive Superabsorbent Dressing 15cm x 25cm||30996||374-4661||EME 077|
Wounds with high levels of exudate can incur increasing costs, both in time and resources and are deeply distressing for patients. It is imperative to heal these wounds as quickly as possible.
Author: Joy Tickle
Publication: JCN 2016, Vol 30, No 5
Date: January 30th, 2017
An observational evaluation of 19 patients with highly exuding wounds using Flivasorb. Flivasorb is a super absorbent dressing that removes harmful exudate from the wound a promotes a healthy wound bed even under compression.
Author: Debby Verrall, Anna Coulborn, Cathie Bree-Aslan
Publication: British Journal of Nursing, March 2010
Date: March 1st, 2010
15 patient study using Flivasorb, Flivasorb handled exudate, promoted healing and patient comfort.
Author: Nathalie Faucher, Helene Safar, Mylène Baret, Anne Philippe and Rachida Farid
Publication: British Journal of Nursing, 2012, Vol 21, No 12
Date: May 1st, 2012
Flivasorb can be used under compression bandages
Author: Justine Whitaker
Publication: EWMA 2012
Date: May 1st, 2012
A 58 year old man with 18 years of lymphoedema. Clothes and slippers smelt offensive from lymphorrhea. Sleeping in a chair and not worn outdoor shoes for 3 years. Happy ending after Flivasorb and Actico , he was sleeping in his bed after 4 weeks and wearing normal shoes and clothes.
Author: Melanie Lewis NHS University Health Board, Swansea
Publication: Poster Presentation, EWMA Conference, Geneva - May 2010
Date: May 1st, 2010
Why early intervention and diagnosis is so important in venous and lymphatic disease
Author: British Journal of Community Nursing
Publication: British Journal of Community Nursing
Date: August 1st, 2012